News
WW International shares are trading higher by 79% during Tuesday's session. The company announced a new partnership with Eli ...
From a fundamental standpoint, Eli Lilly presently has a market capitalization of $789 billion. Over the trailing twelve ...
She suggested I start taking the GLP-1 Zepbound through weekly injections, along with incorporating a healthy diet and ...
WW International (NASDAQ:WW) stock surges with a new partnership to offer Eli Lilly's (LLY) weight-loss therapy Zepbound.
Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...
Medications taken for weight loss are starting to impact wedding planning — and perhaps nothing more than the dress fitting.
Hims and Hers Health Inc. soared in pre-market trading after Novo Nordisk A/S said it would sell its popular weight-loss drug ...
Novo Nordisk said on Tuesday it was partnering with telehealth firms Hims & Hers , Ro and LifeMD to sell branded versions of ...
WeightWatchers (NASDAQ: WW) ("WeightWatchers,” "WW,” or the "Company”), the global leader in science-backed weight management, today announced a pharmacy integration with Eli Lilly and Company's ...
Novo Nordisk, the maker of Wegovy, announced exclusively on " Good Morning America " Tuesday that the medication will soon be available for purchase through the telehealth companies Ro, Hims and ...
Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...
Hims & Hers stock surges after Novo Nordisk announces Wegovy will be offered through telehealth platforms as shortages ease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results